Log in

PILA PILA PHARMA AB OMXSTO · Sweden

PILA PHARMA AB (PILA) news

PILA PHARMA AB is a public biotech or pharmaceutical company listed on OMXSTO under the ticker PILA, recorded under Sweden. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest PILA PHARMA AB news

We have not published a story on PILA PHARMA AB yet. When there is news, it will appear here.

Questions about PILA PHARMA AB

What is the ticker symbol of PILA PHARMA AB?

PILA PHARMA AB trades under the ticker PILA on OMXSTO.

Where is PILA PHARMA AB listed?

PILA PHARMA AB is listed on OMXSTO.

Which country or territory is PILA PHARMA AB listed under?

Our directory records PILA PHARMA AB under Sweden.

What does PILA PHARMA AB do?

Our directory classifies PILA PHARMA AB as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of PILA PHARMA AB?

The ISIN recorded for PILA PHARMA AB is SE0015988274.

Does aibio.space cover PILA PHARMA AB?

aibio.space lists PILA PHARMA AB among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to PILA PHARMA AB?

Companies in our directory listed in the same country and business area as PILA PHARMA AB: NATTARO LABS AB, Active Biotech AB, Cinclus Pharma Holding AB, Bioextrax AB, Xintela AB, Mendus AB.

Investor discussion: PILA PHARMA AB

Members talk about PILA PHARMA AB (PILA). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OMXSTO:PILA on TradingView.

Listing details

PILA PHARMA AB is a public biotech or pharmaceutical company listed on OMXSTO under the ticker PILA, recorded under Sweden. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
PILA PHARMA AB
Ticker
PILA
Listing
OMXSTO
Country or territory
Sweden
Business scope
Biotechnology
ISIN
SE0015988274
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.